Comparison of the metabolic and economic consequences of long‐term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost‐effectiveness analysis

Journal of Evaluation in Clinical Practice 16 (4):744-755 (2010)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,423

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Costs and End-of-Life Care in the NICU: Lessons for the MICU?John D. Lantos & William L. Meadow - 2011 - Journal of Law, Medicine and Ethics 39 (2):194-200.
Impartiality and disability discrimination.Greg Bognar - 2011 - Kennedy Institute of Ethics Journal 21 (1):1-23.
Cost‐effectiveness of pharmacotherapy for COPD in ambulatory care: a review.Steven Simoens - 2013 - Journal of Evaluation in Clinical Practice 19 (6):1004-1011.

Analytics

Added to PP
2013-11-24

Downloads
21 (#720,615)

6 months
3 (#1,002,413)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Tim Baker
University of Leeds

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references